Predictive accuracy of the veterans aging cohort study index for mortality with HIV infection: A north american cross cohort analysis

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 2, 2013, Pages 149-163

  Justice, Amy C ^a   P Modur, Sharada ^b   Tate, Janet P ^c   Althoff, Keri N ^b   Jacobson, Lisa P ^b   Gebo, Kelly A ^b   Kitahata, Mari M ^d   Horberg, Michael A ^e   Brooks, John T ^f   Buchacz, Kate ^f   Rourke, Sean B ^g   Rachlis, Anita ^g   Napravnik, Sonia ^h   Eron, Joseph ^h   Willig, James H ⁱ   Moore, Richard ^j   Kirk, Gregory D ^b   Bosch, Ronald ^k   Rodriguez, Benigno ^l   Hogg, Robert S ^m   Thorne, Jennifer ^b   Goedert, James J ⁿ   Klein, Marina ^o   Gill, John ^p   Deeks, Steven ^q   Sterling, Timothy R ^r   Anastos, Kathryn ^s   Gange, Stephen J ^b   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e DIVISION OF RESEARCH   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ University of Alabama at Birmingham   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m SIMON FRASER UNIVERSITY   (Canada)

ⁿ NATIONAL INSTITUTES OF HEALTH   (United States)

^o MCGILL UNIVERSITY   (Canada)

^p UNIVERSITY OF CALGARY   (Canada)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r VANDERBILT UNIVERSITY   (United States)

^s ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

aging; HIV; prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTIC ACID; CREATININE; HEMOGLOBIN; VIRUS RNA;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH CARE SYSTEM; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORTH AMERICA; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SURVIVAL RATE; THROMBOCYTE;

AGE FACTORS; ALANINE TRANSAMINASE; ANTI-RETROVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CREATININE; FEMALE; HEMOGLOBINS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NORTH AMERICA; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RNA, VIRAL; SEX FACTORS;

EID: 84872860181     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827df36c     Document Type: Article

References (59)

1. McKinnell JA, Willig JH, Westfall AO, et al. Antiretroviral prescribing patterns in treatment-naive patients in the United States. AIDS Patient Care STDS. 2010;24:79-85.
2. D'Arminio MA, Sabin CA, Phillips A, et al. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med. 2005;165:416-423. (Pubitemid 40280197)
3. Hogg R, Lima V, Sterne JA, et al. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299.
4. Losina E, Schackman BR, Sadownik SN, et al. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis. 2009;49:1570-1578.
5. Justice AC, Freiberg MS, Tracy R, et al; and The VACS Project Team. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis. 2012;54:984-994.
6. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep. 2010;7:69-76.
7. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;17:118-123.
8. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS. 2008;22:2409-2418.
9. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Washington, DC: Department Health and Human Services; 2011:1-166.
10. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45:521-528.
11. Feinstein AR. Clinical biostatistics, XIV: the purposes of prognostic stratification. Clin Parmacol Ther. 1972;13:285-297.
12. Feinstein AR, Landis RJ. The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. J Chron Dis. 1979;29:277-284.
13. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006;113:2335-2362. (Pubitemid 43947980)
14. Yourman LC, Lee SJ, Schonberg MA, et al. Prognostic indices for older adults: a systematic review. JAMA. 2012;307:182-192.
15. Turner BJ, Kelly JV, Ball JK. A severity classification system for AIDS hospitalizations. Med Care. 1989;27:423-437.
16. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med. 1989;320: 1388-1393. (Pubitemid 19138934)
17. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119-129. (Pubitemid 34786200)
18. May M, Royston P, Egger M, et al. Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy. Stat Med. 2004; 23:2375-2398. (Pubitemid 39136248)
19. Mocroft AJ, Johnson MA, Sabin CA, et al. Staging system for clinical AIDS patients. Lancet. 1995;346:12-17.
20. Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS. 1999;13:943-950. (Pubitemid 29240189)
21. Harris RJ, Sterne JA, Abgrall S, et al. Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther. 2008; 13:959-967.
22. Lundgren JD, Mocroft A, Gatell JM, et al. A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study. J Infect Dis. 2002;185:178-187. (Pubitemid 34056441)
23. Justice AC, McGinnis KA, Skanderson M, et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2009;11:143-151.
24. Justice AC, Freiberg MS, Tracy R, et al. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis. 2012;54:984-994.
25. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130:515-524. (Pubitemid 29135805)
26. Gange SJ, Kitahata MM, Saag MS, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NAACCORD). Int J Epidemiol. 2007;36:294-301. (Pubitemid 47064328)
27. Lau B, Gange SJ, Moore RD. Interval and clinical cohort studies: epidemiological issues. AIDS Res Hum Retroviruses. 2007;23: 769-776. (Pubitemid 47047915)
28. Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr. 2007;44:179-187. (Pubitemid 46292221)
29. Fultz SL, Skanderson M, Mole LA, et al. Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care. 2006;44:S25-S30. (Pubitemid 44284254)
30. Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2012 Nov 6. [Epub ahead of print]
31. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317-1325. (Pubitemid 43980111)
32. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354:2473-2483. (Pubitemid 43855050)
33. Tate JP, Justice AC; for the VACS Project Team. Change in a prognostic index for survival in HIV infection after one year on cART by level of adherence. Presented at: 48th Annual Meeting of the Infectious Disease Society of America; 21-24 October 2010, Vancouver, British Columbia.
34. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795-802.
35. Cook NR. Assessing the incremental role of novel and emerging risk factors. Curr Cardiovasc Risk Rep. 2010;4:112-119.
36. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-935. (Pubitemid 46294733)
37. D'Agostino RB Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180-187. (Pubitemid 32640849)
38. Cook NR. Comments on 'Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008;27:191-195.
39. Kent DM, Rothwell PM, Ioannidis JP, et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.
40. Hayward RA, Kent DM, Vijan S, et al. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol. 2006;6:18.
41. Eddy DM, Adler J, Patterson B, et al. Individualized guidelines: the potential for increasing quality and reducing costs. Ann Intern Med. 2011;154:627-634.
42. Braithwaite RS. Can life expectancy and QALYs be improved by a framework for deciding whether to apply clinical guidelines to patients with severe comorbid disease? Med Decis Making. 2011;31:582-595.
43. Braithwaite RS, Concato J, Chang CC, et al. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med. 2007;167:2361-2365. (Pubitemid 350179532)
44. Chan CW, Witherspoon JM. Health risk appraisal modifies cigarette smoking behavior among college students. J Gen Intern Med. 1988;3: 555-559. (Pubitemid 19046633)
45. Dapp U, Anders JA, von Renteln-Kruse W, et al. A randomized trial of effects of health risk appraisal combined with group sessions or home visits on preventive behaviors in older adults. J Gerontol A Biol Sci Med Sci. 2011;66:591-598.
46. Kreuter MW, Strecher VJ. Do tailored behavior change messages enhance the effectiveness of health risk appraisal? Results from a randomized trial. Health Educ Res. 1996;11:97-105. (Pubitemid 26090452)
47. Maron DJ, Forbes BL, Groves JR, et al. Health-risk appraisal with or without disease management for worksite cardiovascular risk reduction. J Cardiovasc Nurs. 2008;23:513-518.
48. Stuck AE, Kharicha K, Dapp U, et al. The PRO-AGE study: an international randomised controlled study of health risk appraisal for older persons based in general practice. BMC Med Res Methodol. 2007;7:2.
49. Justice AC, Tate JP, Freiberg MS, et al. Reply to Chow et al. Clin Infect Dis. 2012 Jun 10. [Epub ahead of print]
50. Akgun KM, Pisani MA, Fried TR, et al. Risk factors for medical intensive care Unit admission in HIV infected veterans. AIDS. 2012 Oct 29. [Epub ahead of print]
51. Erlandson KM, Allshouse AA, Jankowski C. Prospective comparison of three functional assessments with the Veteran's Aging Cohort Study index in virologically suppressed HIV-infected adults. Presented at: 2nd International Workshop on HIV and Aging; Baltimore, Maryland, October 27-28, 2011. Abstract #8.
52. Womack JA, Goulet JL, Gibert C, et al. Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One. 2011;6:e17217.
53. May MT, Sterne JA, Costagliola D, et al. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet. 2006;368: 451-458.
54. Tate J, Freiberg M, Justice AC. Do risk factors for cardiovascular disease improve VACS index prediction of all cause mortality? Presented at: International Cohorts Meeting; Athens, Greece, March 27-29, 2012.
55. Oursler K., Tate J., Gill T., et al; and Veterans Aging Cohort Study Project Team. Comorbidity is predictive of Muscle Strength in HIVinfected veterans: results from the vacs index. Presented at: 19th Conference on Retroviruses and Opportunistic Infections; Seattle, Washington, March 8, 2012.
56. Pencina MJ, D'Agostino RB, Vasan SR. Evaluating the additive predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:207-212.
57. Schafer JL. Analysis of Incomplete Multivariate Data. London, United Kingdom: Chapman and Hall CRC Press; 1997.
58. Gelman A, Carlin JB, Stern HS, et al. Bayesian Data Analysis. London, United Kingdom: Chapman and Hall CRC Press; 2003.
59. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387. (Pubitemid 26072233)